164 related articles for article (PubMed ID: 11477489)
41. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
Afif-Abdo J; Teloken C; Damião R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
[TBL] [Abstract][Full Text] [Related]
42. [Hypertension and impotence. Which potency drug is the most appropriate here?].
Köhn FM
MMW Fortschr Med; 2002 Mar; 144(10):12-3. PubMed ID: 11928255
[No Abstract] [Full Text] [Related]
43. Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
Reffelmann T; Kloner RA
Expert Opin Drug Saf; 2005 May; 4(3):531-40. PubMed ID: 15934858
[TBL] [Abstract][Full Text] [Related]
44. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
Chen JJ; Obering C
Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of apomorphine SL in erectile dysfunction.
Mirone VG; Stief CG
BJU Int; 2001 Oct; 88 Suppl 3():25-9. PubMed ID: 11578276
[No Abstract] [Full Text] [Related]
46. A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction.
Perimenis P; Gyftopoulos K; Giannitsas K; Markou SA; Tsota I; Chrysanthopoulou A; Athanasopoulos A; Barbalias G
Int J Impot Res; 2004 Feb; 16(1):2-7. PubMed ID: 14963464
[TBL] [Abstract][Full Text] [Related]
47. Comparative trial of treatment satisfaction, efficacy and tolerability of sildenafil versus apomorphine in erectile dysfunction--an open, randomized cross-over study with flexible dosing.
Porst H; Behre HM; Jungwirth A; Burkart M
Eur J Med Res; 2007 Feb; 12(2):61-7. PubMed ID: 17369119
[TBL] [Abstract][Full Text] [Related]
48. The role of apomorphine SL in the treatment of male erectile dysfunction.
Heaton JP; Altwein JE
BJU Int; 2001 Oct; 88 Suppl 3():36-8. PubMed ID: 11578278
[No Abstract] [Full Text] [Related]
49. Erectile dysfunction.
Tharyan P; Gopalakrishanan G
Clin Evid; 2006 Jun; (15):1227-51. PubMed ID: 16973050
[No Abstract] [Full Text] [Related]
50. Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study.
Perimenis P; Markou S; Gyftopoulos K; Giannitsas K; Athanasopoulos A; Liatsikos E; Barbalias G
Andrologia; 2004 Jun; 36(3):106-10. PubMed ID: 15206909
[TBL] [Abstract][Full Text] [Related]
51. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
[TBL] [Abstract][Full Text] [Related]
52. Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine.
Hsieh GC; Hollingsworth PR; Martino B; Chang R; Terranova MA; O'Neill AB; Lynch JJ; Moreland RB; Donnelly-Roberts DL; Kolasa T; Mikusa JP; McVey JM; Marsh KC; Sullivan JP; Brioni JD
J Pharmacol Exp Ther; 2004 Jan; 308(1):330-8. PubMed ID: 14569075
[TBL] [Abstract][Full Text] [Related]
53. Recovery of erectile function by the oral administration of apomorphine.
Heaton JP; Morales A; Adams MA; Johnston B; el-Rashidy R
Urology; 1995 Feb; 45(2):200-6. PubMed ID: 7855966
[TBL] [Abstract][Full Text] [Related]
54. Exposure of juvenile rats to the phytoestrogen daidzein impairs erectile function in a dose-related manner in adulthood.
Pan L; Xia X; Feng Y; Jiang C; Cui Y; Huang Y
J Androl; 2008; 29(1):55-62. PubMed ID: 17673432
[TBL] [Abstract][Full Text] [Related]
55. New oral agents for erectile dysfunction: what is changing in our practice?
Aversa A; Fabbri A
Asian J Androl; 2001 Sep; 3(3):175-9. PubMed ID: 11561186
[TBL] [Abstract][Full Text] [Related]
56. Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury.
Strebel RT; Reitz A; Tenti G; Curt A; Hauri D; Schurch B
BJU Int; 2004 Jan; 93(1):100-4. PubMed ID: 14678378
[TBL] [Abstract][Full Text] [Related]
57. Restoration of erectile capacity in normotensive aged rats by modulation of angiotensin receptor type 1.
Park K; Shin JW; Oh JK; Ryu KS; Kim SW; Paick JS
J Androl; 2005; 26(1):123-8. PubMed ID: 15611576
[TBL] [Abstract][Full Text] [Related]
58. [Experiences with apomorphine SL in studies: tolerated therapy--even in problem patients].
MMW Fortschr Med; 2002 May; Suppl 2():83. PubMed ID: 12070860
[No Abstract] [Full Text] [Related]
59. The pharmacology and clinical pharmacokinetics of apomorphine SL.
Argiolas A; Hedlund H
BJU Int; 2001 Oct; 88 Suppl 3():18-21. PubMed ID: 11578274
[No Abstract] [Full Text] [Related]
60. Novel treatment options for overlapping yet distinct erectile dysfunction and andropause syndromes.
Tan RS
Curr Opin Investig Drugs; 2003 Apr; 4(4):435-8. PubMed ID: 12808883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
